Literature DB >> 10477597

TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related.

C S Shi1, A Leonardi, J Kyriakis, U Siebenlist, J H Kehrl.   

Abstract

TNF-induced activation of stress activated protein kinases (SAPKs, Jun NH2-terminal kinases) requires TNF receptor associated factor 2 (TRAF2). TRAF2 is a potent activator of a 95-kDa serine/threonine kinase termed germinal center kinase related (GCKR, also referred to as KHS1), which signals activation of the SAPK pathway. Consistent with a role for GCKR in TNF- induced SAPK activation, a kinase-inactive mutant of GCKR is a dominant negative inhibitor of TRAF2-induced SAPK activation. Here we show that TRAF2 interacts with GCKR. This interaction depended upon the TRAF domain of TRAF2 and the C-terminal 150 aa of GCKR. The full activation of GCKR by TRAF2 required the TRAF2 RING finger domain. TNF treatment of a T cell line, Jurkat, increased both GCRK and SAPK activity and enhanced the coimmunoprecipitation of GCKR with TRAF2. Similar results were found with the B cell line HS-Sultan. These findings are consistent with a model whereby TNF signaling results in the recruitment and activation of GCKR by TRAF2, which leads to SAPK activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477597

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin.

Authors:  H Liu; H Nishitoh; H Ichijo; J M Kyriakis
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  The mitogen-activated protein kinase kinase kinase kinase GCKR positively regulates canonical and noncanonical Wnt signaling in B lymphocytes.

Authors:  Chong-Shan Shi; Ning-Na Huang; Kathleen Harrison; Sang-Bae Han; John H Kehrl
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  A genetic screen targeting the tumor necrosis factor/Eiger signaling pathway: identification of Drosophila TAB2 as a functionally conserved component.

Authors:  Peter Geuking; Rajesh Narasimamurthy; Konrad Basler
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

Review 4.  Amino acid regulation of TOR complex 1.

Authors:  Joseph Avruch; Xiaomeng Long; Sara Ortiz-Vega; Joseph Rapley; Angela Papageorgiou; Ning Dai
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

5.  The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase.

Authors:  Thomas H Lee; Qiaojia Huang; Sarah Oikemus; Jennifer Shank; Juan-Jose Ventura; Nicole Cusson; Richard R Vaillancourt; Bing Su; Roger J Davis; Michelle A Kelliher
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 6.  Signaling by CD40 and its mimics in B cell activation.

Authors:  G A Bishop; B S Hostager
Journal:  Immunol Res       Date:  2001       Impact factor: 4.505

7.  Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40.

Authors:  Takanori So; Michael Croft
Journal:  Front Immunol       Date:  2012-05-28       Impact factor: 7.561

8.  Suppressor of cytokine signaling 3 plays an important role in porcine circovirus type 2 subclinical infection by downregulating proinflammatory responses.

Authors:  Xuejiao Zhu; Juan Bai; Panrao Liu; Xianwei Wang; Ping Jiang
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

9.  TS: a powerful truncated test to detect novel disease associated genes using publicly available gWAS summary data.

Authors:  Jianjun Zhang; Xuan Guo; Samantha Gonzales; Jingjing Yang; Xuexia Wang
Journal:  BMC Bioinformatics       Date:  2020-05-04       Impact factor: 3.169

Review 10.  The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.

Authors:  Shuai Wang; Lili Zhou; Li Ling; Xuli Meng; Feng Chu; Suping Zhang; Fangfang Zhou
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.